Tumor progression by immune evasion in melanoma
Open Access
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Tumor cell expression of programmed cell death‐1 ligand 1 is a prognostic factor for malignant melanomaCancer, 2010
- A Multimarker Prognostic Assay for Primary Cutaneous MelanomaClinical Cancer Research, 2009
- Identifying and Overcoming Immune Resistance Mechanisms in the Melanoma Tumor MicroenvironmentClinical Cancer Research, 2006
- Biologic and Prognostic Significance of Dermal Ki67 Expression, Mitoses, and Tumorigenicity in Thin Invasive Cutaneous MelanomaJournal of Clinical Oncology, 2005
- Biomarkers for melanomaCurrent Opinion in Oncology, 2005
- Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic targetProceedings of the National Academy of Sciences, 2004
- Erratum: Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasionNature Medicine, 2002
- Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging SystemJournal of Clinical Oncology, 2001
- The Hallmarks of CancerCell, 2000
- Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanomaCancer, 1996